Abstract

The vulva is an unusual site for basal cell carcinoma (BCC). Vulvar BCC accounts for <1% of all BCCs and <5% of all vulvar malignancies. We report the case of an 83year-old woman who presented with a 2-month history of a tender labial growth, with histopathology confirming nodular BCC. We conducted a systematic literature review of the characteristics of reported cases of vulvar BCCs. A comprehensive systematic review of articles indexed for MEDLINE and Embase yielded 96 reports describing 437 patients with 446 BCCs of the vulva. The mean age at presentation was 70 (range 20-100). Most women had no underlying vulvar disease. Approximately 60% of cases were of the nodular subtype. Treatment approach varied widely with over half of cases treated with wide local or local excision. Mohs micrographic surgery (MMS) for vulvar BCC was first reported in 1988 with seven total MMS cases reported. Twenty-three cases of recurrence have been reported; 21 of these cases after local excision but none following MMS. Vulvar BCC is a rarely reported cancer that affects older women predominantly. MMS represents a promising treatment for BCC in this anatomic location.

Highlights

  • We report the case of an 83 year-old woman who presented with a two-month history of a tender labial growth, with histopathology confirming nodular basal cell carcinoma (BCC)

  • While basal cell carcinomas (BCC) are the most common human malignancy, the vulva is an unusual location with vulvar BCCs accounting for less than 1% of all BCCs.[1]

  • We report the case of an 83 year-old woman who presented with a BCC of the vulva

Read more

Summary

Local excision

Pt died of squamous cell CA of lung 11 yrs after biopsy of primary BCC lesion. Pt’s lungs deteriorated and she died of respiratory failure due to lung metastases

Renal cell
Wide excision
Infiltrated deep and lateral subcutaneous tissues
Lesion completely excised
Ulceration and necrosis to the depth of the symphysis pubis
Findings
Supraclavicular lymph node
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.